The Biological Rhythm of Human Metabolite

Sponsor
Shandong Provincial Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03669809
Collaborator
(none)
200
1
468
0.4

Study Details

Study Description

Brief Summary

The circadian regulation in mammals have been known for a long time. A special group of clock genes, organized in feedback loops, are responsible for the circadian regulation in both the SCN and peripheral organs. The central clock is mainly entrained by the light-dark cycle, while the peripheral ones in organs such as liver and intestine, are more influenced by the feeding-fasting cycles. The coordination of central and peripheral clocks is thought to be essential in the maintenance of physiological homeostasis.This study aim to investigate the association between biological rhythm and metabolism.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Other
    Official Title:
    Association Between Serum Metabolism Markers and Biological Rhythm
    Study Start Date :
    May 1, 2011
    Anticipated Primary Completion Date :
    May 1, 2050
    Anticipated Study Completion Date :
    May 1, 2050

    Arms and Interventions

    Arm Intervention/Treatment
    male, non-obese

    male with BMI<28

    male, obese

    male with BMI≥28

    female, non-obese

    female with BMI<28

    female, obese

    female with BMI≥28

    Outcome Measures

    Primary Outcome Measures

    1. circadian rhythms of serum lipid levels (the change of serum lipid levels within 24 hours) [Measured at baseline, and every 10 years during the 40-year follow-up period]

    Secondary Outcome Measures

    1. circadian rhythms of gonadal hormone and gonadotropin(the change of gonadal hormone and gonadotropin within 24 hours) [Measured at baseline, and every 10 years during the 40-year follow-up period]

    2. circadian rhythms of serum total bile acids(the change of serum total bile acids within 24 hours) [Measured at baseline, and every 10 years during the 40-year follow-up period]

    3. change in urine metabolite [Measured at baseline, and every 10 years during the 40-year follow-up period]

    4. change in intestinal flora [Measured at baseline, and every 10 years during the 40-year follow-up period]

    5. change in sperm quality [Measured at baseline, and every 10 years during the 40-year follow-up period]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 30 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Male or female;

    • Aged of 18 to 30 years old;

    Exclusion Criteria:
    • Presence of pituitary/hypothalamic disorders, polycystic ovarian syndrome, thyroid disorders, hypertension, malignant tumor, cardiac insufficiency,hepatic or renal insufficiency, gastrointestinal disorders and acute infection;

    • Receiving psychotropic or hormonal medications including hormonal contraception and hormone therapies;

    • Taking lipid-lowering agents or hypoglycemic agents and other drugs that known to influence cardiovascular health;

    • Pregnancy or lactation women;

    • Obviously poor compliance.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Shandong Provincial Hospital Jinan Shandong China 250021

    Sponsors and Collaborators

    • Shandong Provincial Hospital

    Investigators

    • Study Chair: Jiajun Zhao, Shandong Provincial Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jia-jun Zhao, Professor, Shandong Provincial Hospital
    ClinicalTrials.gov Identifier:
    NCT03669809
    Other Study ID Numbers:
    • 20180326
    First Posted:
    Sep 13, 2018
    Last Update Posted:
    May 11, 2022
    Last Verified:
    Nov 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jia-jun Zhao, Professor, Shandong Provincial Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 11, 2022